Vivo brings together trial data, AI reasoning, continuous monitoring, evidence generation, and workflow action so teams can understand status, detect risk, and coordinate response across studies and portfolios.
Clinical trials generate more data than ever, but most study teams still manage execution through disconnected systems, vendor portals, CRO reports, spreadsheets, and periodic status updates. That creates a gap between when data is collected and when teams can act on it. Vivo closes that gap.
Vivo ingests, harmonizes, and monitors structured and semi-structured trial data across systems. Every source remains traceable. Cross-domain review becomes possible across subjects, sites, visits, endpoints, labs, adverse events, vendors, and documents.
Supported source categories:
"A clinical trial is not one system. Vivo gives teams one operating picture."
Integration approach
Trial Home — Daily View
Trial Home gives study teams a continuously updated view of what is happening across the trial, what changed since the last review, what needs attention, and what actions are pending. Designed for the rhythm of real clinical development work.
"Know what changed before the meeting starts."
Ask Vivo gives clinical development teams a governed AI interface to their own trial data, documents, protocol context, and operating workflows. Not a chatbot — a source-backed reasoning layer designed for clinical use.
"Ask the trial. See the evidence."
A signal is only valuable if the right team sees it, understands it, and acts on it. Vivo continuously monitors trial data and turns signals into governed action.
Continuously watch for missing, late, inconsistent, unexpected, or high-risk patterns across all connected sources.
Generate governed alerts with source evidence and affected entities. Share across the team. Set thresholds from protocols or Ask Vivo prompts.
Convert alerts to issues. Assign ownership. Track resolution. Preserve evidence packages for audit, inspection, and review.
Vivo monitors for risk across:
Vivo helps clinical development leaders move beyond study-by-study updates into portfolio-level intelligence. See where attention is needed, then drill into the study, site, subject, vendor, or data domain driving the issue.
"One study creates clarity. A portfolio creates operating leverage."
Portfolio Risk View
Vivo explains what changed and what action should follow.
Vivo monitors the trial and connects answers to source-backed workflows.
Vivo helps clinical teams interpret, prioritize, and act on data.
Vivo connects risk to evidence, issues, review workflows, and portfolio context.
"Our CMO went from spending a week plus manually collating and creating the various tables he wanted for DSMB to maybe 30, 45 minutes. That's just transformative to how we do business."
VP, Clinical Operations · Alzheimer's Disease Global Phase 2 TrialVivo helps clinical development teams understand what changed, detect risk earlier, ask better questions, and coordinate response with source-backed evidence.